University of Edinburgh spinout Carbogenics has announced it has raised more than £1m in investment to build its first green energy production and R&D facility.
The University of Edinburgh has again been ranked among the world’s top universities by The Times Higher Education Impact Rankings for its contribution to the UN SDGs, maintaining 5th place globally for Industry, Innovation and Infrastructure.
Over 200 academics and industry partners came together at the National Museum of Scotland yesterday for Edinburgh Innovations’ annual showcase and dinner, this year on the theme of Digital Frontiers: data and digital technologies.
Biotechnology spinout Kynos Therapeutics Ltd has announced that dosing is underway in a first in-human phase I trial of its lead drug candidate, KNS366.
A new drug candidate for hard-to-treat cancers, discovered at the University of Edinburgh and licensed by biopharmaceutical company Nuvectis Pharma, Inc., has received US Food and Drug Administration (FDA) clearance to proceed to clinical trials.
An algorithm developed using artificial intelligence could soon be used by doctors to diagnose heart attacks with better speed and accuracy than ever before, according to new research from the University of Edinburgh, funded by charity the British Heart Foundation and the UK’s National Institute for Health and Care Research, and published today in Nature Medicine.
